T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Oil-Dri
ODC
$1.27B
| $20.4M | ﹤0.01% |
1,251,412
+600
| +0% | +$8.68K |
|
|
ATW
1102
DELISTED
Atwood Oceanics
ATW
| $20.3M | ﹤0.01% |
716,830
-285,250
| -28% | -$10.2M |
|
1103
Skyworks Solutions
SWKS
$10.5B
| $20.3M | ﹤0.01% |
279,588
-13,119
| -4% | -$814K |
|
|
THR
1104
DELISTED
Thermon Group Holdings
THR
| $20.2M | ﹤0.01% |
833,910
+5,710
| +0.7% | +$136K |
|
1105
Weyco Group
WEYS
$437M
| $20.2M | ﹤0.01% |
679,620
+700
| +0.1% | +$19.5K |
|
|
BCR
1106
DELISTED
CR Bard Inc.
BCR
| $20.1M | ﹤0.01% |
120,704
-6,590
| -5% | -$1.07M |
|
|
PENX
1107
DELISTED
PENFORD CORP
PENX
| $20M | ﹤0.01% |
1,067,800
-51,300
| -5% | -$909K |
|
|
PSTB
1108
DELISTED
Park Sterling Corp.
PSTB
| $19.9M | ﹤0.01% |
2,712,367
+1,645,000
| +154% | +$11.7M |
|
1109
Molson Coors Class B
TAP
$7.86B
| $19.8M | ﹤0.01% |
265,938
+410
| +0.2% | +$30.4K |
|
1110
Generac Holdings
GNRC
$12.8B
| $19.8M | ﹤0.01% |
423,237
-152,748
| -27% | -$6.68M |
|
|
LVNTA
1111
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $19.8M | ﹤0.01% |
524,238
-379,238
| -42% | -$13.2M |
|
|
SHOR
1112
DELISTED
ShoreTel, Inc.
SHOR
| $19.6M | ﹤0.01% |
2,669,362
-22,200
| -0.8% | -$164K |
|
|
CUDA
1113
DELISTED
Barracuda Networks, Inc.
CUDA
| $19.5M | ﹤0.01% |
545,380
-100,577
| -16% | -$3.31M |
|
1114
Dover
DOV
$27.8B
| $19.5M | ﹤0.01% |
336,023
-990
| -0.3% | -$61.4K |
|
|
SHLO
1115
DELISTED
Shiloh Industries Inc
SHLO
| $19.5M | ﹤0.01% |
1,237,494
-207,166
| -14% | -$3.35M |
|
1116
Eastman Chemical
EMN
$8.42B
| $19.4M | ﹤0.01% |
256,014
+14,100
| +6% | +$1.11M |
|
|
HAWK
1117
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $19.4M | ﹤0.01% |
505,052
+462,690
| +1,092% | +$16.5M |
|
1118
Tyson Foods
TSN
$19.9B
| $19.4M | ﹤0.01% |
483,084
+3,820
| +0.8% | +$155K |
|
|
AVDL
1119
DELISTED
Avadel Pharmaceuticals
AVDL
| $19.3M | ﹤0.01% |
1,128,000
+665,900
| +144% | +$9.51M |
|
1120
Clearway Energy Class C
CWEN
$7.03B
| $19.3M | ﹤0.01% |
818,300
+9,800
| +1% | +$228K |
|
1121
Ameren
AEE
$30.3B
| $19.3M | ﹤0.01% |
418,019
-30,490
| -7% | -$1.3M |
|
1122
Utah Medical Products
UTMD
$229M
| $19.1M | ﹤0.01% |
317,540
+100
| +0% | +$5.54K |
|
1123
Live Nation Entertainment
LYV
$43.3B
| $19M | ﹤0.01% |
727,900
+20,200
| +3% | +$509K |
|
1124
TSMC
TSM
$2.23T
| $19M | ﹤0.01% |
846,816
+767,444
| +967% | +$16.7M |
|
|
VAL
1125
DELISTED
Valspar
VAL
| $18.9M | ﹤0.01% |
218,075
+100
| +0% | +$8.21K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.